Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 2:18 PM ET


Company Overview of Moderna Therapeutics, Inc.

Company Overview

Moderna Therapeutics, Inc. develops messenger RNA therapeutics. The company provides in vivo drug modality that produces human proteins or antibodies inside patient cells. It also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. The company focuses on disease areas, such as inherited genetic disorders, hemophilic and blood factors, and oncology. Moderna Therapeutics, Inc. has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals, Inc.; and strategic collaborations with Karolinska Institutet, Institut Pasteur, and Karolinska University Hospital. The company was incorporated in 2009 and is based...

200 Tech Square

Cambridge, MA 02139

United States

Founded in 2009





Key Executives for Moderna Therapeutics, Inc.

Founding Chief Executive Officer, President and Director
Age: 42
Co-Founder, Chairman and Member of Technology Advisory Board
Age: 52
Chief Financial Officer
Age: 41
President of Research and Development
Age: 61
Senior Vice President of Technology Strategy
Age: 56
Compensation as of Fiscal Year 2015.

Moderna Therapeutics, Inc. Key Developments

Moderna Therapeutics, Inc. Presents at 22nd Annual NewsMakers in the Biotech Industry Investment Conference, Sep-10-2015 10:30 AM

Moderna Therapeutics, Inc. Presents at 22nd Annual NewsMakers in the Biotech Industry Investment Conference, Sep-10-2015 10:30 AM. Venue: Millennium Broadway Hotel & Conference Center - Breakout Room 401, 145 West 44th Street, New York, New York, United States.

Moderna Launches Third Venture Company Elpidera for Rare Diseases

Moderna Therapeutics announced the launch of Elpidera LLC, a new Moderna venture focused exclusively on the advancement of mRNA-based medicines for the treatment of rare diseases. Elpidera, which is derived from the Greek word elpida meaning "hope," will leverage Moderna's mRNA platform to create novel therapies to address diseases in small patient populations with severe unmet medical needs. Moderna signed a strategic agreement with Alexion in January 2014 allowing Alexion to have 10 product options in rare diseases. Elpidera will advance programs that are independent from the Alexion programs and proprietary to Moderna, while also supporting Alexion in its efforts to leverage the Moderna technology platform through the existing agreement.

Moderna Therapeutics, Inc. Names Tal Zaks as Chief Medical Officer, Effective March 16, 2015

Moderna Therapeutics, Inc. announced that Tal Zaks, M.D., Ph.D., will join Moderna's executive leadership team as chief medical officer, effective March 16. Prior to joining Moderna, Dr. Zaks was senior vice president and head of Global Oncology at Sanofi.

Similar Private Companies By Industry

Company Name Region
BioPharm Solutions, Inc. United States
Elusys Therapeutics, Inc. United States
SureGene, LLC United States
True North Therapeutics, Inc. United States
Click Therapeutics, Inc. United States

Recent Private Companies Transactions

Private Placement
December 19, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Moderna Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at